🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Comparator Quadrivalent Inactivated Influenza Vaccine

Found 29 matching trials

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

PHASE2

This is a multi-center, randomized, double-blind, active comparator control...

Status

Unknown

Location

Optimal Research

Start Date

2015-05

Trial ID

NCT02434276

Treatments Being Tested

VAX2012Q Fluzone Quadrivalent

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

PHASE3

This phase 3 clinical study is a randomized, observer-blind, comparator-con...

Status

Completed

Location

84035 CCR Research

Start Date

2019-09-06

Trial ID

NCT04074928

Treatments Being Tested

QIVc Comparator QIV

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

PHASE2

Elderly healthy subjects will be once administered GC3114A(High-dose Quadri...

Status

Completed

Location

Korea University Guro Hospital

Start Date

2018-10-01

Trial ID

NCT03657719

Treatments Being Tested

GC3114 GCFLU Quadrivalent

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

PHASE3

This is a study to assess the immune (antibody) response and safety of a Se...

Status

Completed

Location

Site 434

Start Date

2016-09-27

Trial ID

NCT02914275

Treatments Being Tested

Seqirus Quadrivalent Inactivated Influenza Vaccine Comparator Quadrivalent Inactivated Influenza Vaccine

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

PHASE1

Healthy adults will be once administered GC3114A(High-dose Quadrivalent inf...

Status

Completed

Location

Korea University Guro Hospital

Start Date

2017-11-20

Trial ID

NCT03357263

Treatments Being Tested

GC3114 GCFLU Quadrivalent

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age

PHASE3

A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...

Status

Completed

Location

MHAT St. Ekaterina

Start Date

2016-09-30

Trial ID

NCT02587221

Treatments Being Tested

MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)Non-Influenza Comparator (Boostrix)

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)

PHASE1

The purpose of this study is to evaluate the safety, tolerance, and immunog...

Status

Unknown

Location

Saint Louis University School of Medicine

Start Date

2015-07

Trial ID

NCT02500680

Treatments Being Tested

MER4101 Inactivated Influenza Vaccine

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

PHASE3

This Phase 3/4, randomized, observer-blind, multi-center study, stratified ...

Status

Completed

Location

302 AusTrials Pty Ltd

Start Date

2017-05-25

Trial ID

NCT03165617

Treatments Being Tested

QIVc Non-influenza Comparator Vaccine

A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.

PHASE3

The purpose of this study is to evaluate the clinical lot-to-lot consistenc...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-10-26

Trial ID

NCT05045144

Treatments Being Tested

RSVPreF3(120 μg)Flu Quadrivalent influenza vaccine (15 μg HA)Placebo

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

PHASE1

This is a Phase 1, single-site, comparator-controlled, dosage-escalating st...

Status

Completed

Location

University of Iowa - Infectious Disease Clinic

Start Date

2023-10-16

Trial ID

NCT05945485

Treatments Being Tested

DCVC H1 HA mRNA vaccine Quadrivalent Recombinant Seasonal Influenza Vaccine Sodium Chloride, 0.9%

Previous Next